ARAY Latest Report

Financial Performance

At the end of 2024, ARAY's total operating revenue was US$1161.74 million, up approximately 8.30% from US$1072.38 million at the end of 2023. This growth reflects the company's improvement in sales and market demand.

Key Financial Data

1. ARAY's total operating revenue increased from US$1072.38 million in 2023 to US$1161.74 million in 2024, up approximately 8.30%.

2. In 2024, ARAY's gross profit was US$4189.20 million, a significant increase from US$3590.20 million in 2023, reflecting the company's improvement in cost control and profitability.

3. Sales costs increased to US$7428.20 million, but the gross margin improved, showing the company's adaptability in the competitive market.

Industry Comparison

1. Overall industry analysis: In 2024, the overall medical equipment industry's operating revenue generally increased, especially in the technology and medical equipment sectors, benefiting from the recovery of market demand and the launch of innovative products. ARAY's revenue growth is in line with industry trends, indicating its enhanced competitiveness in the market.

2. Peer evaluation analysis: ARAY's operating revenue growth rate of 8.30% is in the middle and upper levels of the same industry, showing its competitive advantage in the market. In contrast, some competitors face challenges such as market saturation and increased competition.

Summary

ARAY's revenue growth in 2024 reflects its improved market demand and effective sales strategy adjustments. Compared with peers, ARAY shows a stable growth trend, indicating its competitive position in the industry.

Opportunities

1. The successful launch of new products (such as XREAL One AR glasses) may further enhance market share and revenue.

2. Changes in medical equipment industry policies (such as the trade-in policy) will bring new market opportunities, which ARAY can seize by timely strategy adjustments.

3. Strengthening sales strategies and channel expansion in the European and American markets can help drive the company's continuous growth.

Risks

1. Increased competition in the industry may affect ARAY's market share and profitability.

2. Increased global economic uncertainty may lead to market demand fluctuations, negatively affecting sales.

3. Changes in regulatory policies may affect the overall operating environment of the medical equipment industry, and ARAY needs to remain sensitive to policy changes.